Best Penny Stocks Under 25 Cents Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. These penny stocks all have a super-low share price of $0.25 or less and are sorted by average trading volume in dollars. These companies are considered the most actively-traded stocks priced under $0.25. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. Sunnova Energy International NYSE:NOVA$0.19 -0.04 (-17.92%) As of 03:47 PM EasternSunnova Energy International Inc engages in the provision of energy as a service in the United States. The company offers electricity, as well as offers operations and maintenance, monitoring, repairs and replacements, equipment upgrades, on-site power optimization, and solar energy system and energy storage system diagnostics services. More about Sunnova Energy InternationalMarket Capitalization$23.15 millionP/E Ratio-0.06Consensus RatingHoldConsensus Price Target$4.93 (+2,564.4% Upside)Volume6.69 million sharesAverage Volume17.25 million shares Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. Nikola NASDAQ:NKLA$0.18 -0.07 (-28.74%) Closing price 02/25/2025Extended Trading$0.18 0.00 (0.00%) As of 02/25/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nikola Corporation operates as a technology innovator and integrator that develops energy and transportation solutions in the United States and internationally. More about NikolaMarket Capitalization$11.14 millionP/E Ratio-0.01Consensus RatingHoldConsensus Price Target$12.00 (+6,457.4% Upside)Volume36.66 million sharesAverage Volume8.73 million shares3. LanzaTech Global NASDAQ:LNZA$0.24 0.00 (0.00%) As of 03:46 PM EasternLanzaTech Global, Inc operates as a nature-based carbon refining company in the United States and internationally. The company transforms waste carbon into the chemical building blocks for consumer goods, such as sustainable fuels, fabrics, and packaging. More about LanzaTech GlobalMarket Capitalization$47.46 millionP/E Ratio-0.37Consensus RatingHoldConsensus Price Target$2.00 (+733.3% Upside)Volume648,938 sharesAverage Volume2.33 million shares4. Wag! Group NASDAQ:PET$0.15 0.00 (0.00%) As of 03:44 PM EasternWag! Group Co develops and supports a proprietary marketplace technology platform available as a website and mobile app that enables independent pet caregivers to connect with pet parents. More about Wag! GroupMarket Capitalization$7.38 millionP/E Ratio-0.37Consensus RatingModerate BuyConsensus Price Target$4.90 (+3,267.7% Upside)Volume1.86 million sharesAverage Volume3.12 million shares5. Palatin Technologies NYSEAMERICAN:PTN$0.19 -0.02 (-8.29%) As of 03:43 PM EasternPalatin Technologies, Inc, a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. More about Palatin TechnologiesMarket Capitalization$4.89 millionP/E Ratio-0.12Consensus RatingBuyConsensus Price Target$7.00 (+3,623.4% Upside)Volume1.69 million sharesAverage Volume2.12 million shares6. Omega Therapeutics NASDAQ:OMGA$0.12 -0.03 (-21.83%) Closing price 02/24/2025Extended Trading$0.12 0.00 (0.00%) As of 02/24/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Omega Therapeutics, Inc operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by restoring aberrant gene expression to a range without altering native nucleic acid sequences. More about Omega TherapeuticsMarket Capitalization$6.92 millionP/E Ratio-0.09Consensus RatingModerate BuyConsensus Price Target$9.20 (+7,260.0% Upside)Volume4.81 million sharesAverage Volume2.89 million shares7. Beyond Air NASDAQ:XAIR$0.20 -0.01 (-2.88%) As of 03:44 PM EasternBeyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. More about Beyond AirMarket Capitalization$13.47 millionP/E Ratio-0.18Consensus RatingBuyConsensus Price Target$1.50 (+666.1% Upside)Volume653,352 sharesAverage Volume1.71 million shares8. Helius Medical Technologies NASDAQ:HSDT$0.24 -0.04 (-14.59%) As of 03:39 PM EasternHelius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. More about Helius Medical TechnologiesMarket Capitalization$1.48 millionP/E Ratio-0.04Consensus RatingHoldVolume292,767 sharesAverage Volume1.38 million sharesToday's Range$0.22▼$0.269. IN8bio NASDAQ:INAB$0.17 0.00 (-1.10%) As of 03:43 PM EasternIN8bio, Inc, a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. More about IN8bioMarket Capitalization$13.82 millionP/E Ratio-0.23Consensus RatingBuyConsensus Price Target$6.00 (+3,427.3% Upside)Volume340,288 sharesAverage Volume1.84 million shares10. Gryphon Digital Mining NASDAQ:GRYP$0.24 -0.03 (-11.28%) As of 03:39 PM EasternGryphon Digital Mining, Inc operates as a bitcoin mining company in the United States. It operates mining computers and ESG-led mining. More about Gryphon Digital MiningMarket Capitalization$16.57 millionP/E Ratio-0.44Consensus RatingHoldVolume397,766 sharesAverage Volume1.09 million sharesToday's Range$0.24▼$0.2711. Lyra Therapeutics NASDAQ:LYRA$0.12 0.00 (-0.42%) As of 03:38 PM EasternLyra Therapeutics, Inc, a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. More about Lyra TherapeuticsMarket Capitalization$7.74 millionP/E Ratio-0.08Consensus RatingHoldConsensus Price Target$1.25 (+963.8% Upside)Volume2.13 million sharesAverage Volume2.05 million shares12. Processa Pharmaceuticals NASDAQ:PCSA$0.24 +0.01 (+5.36%) As of 03:39 PM EasternProcessa Pharmaceuticals, Inc, a clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment. More about Processa PharmaceuticalsMarket Capitalization$1.27 millionP/E Ratio-0.07Consensus RatingBuyConsensus Price Target$6.00 (+2,382.4% Upside)Volume2.42 million sharesAverage Volume909,030 shares13. Bio-Path NASDAQ:BPTH$0.14 -0.02 (-15.56%) As of 11:42 AM EasternBio-Path Holdings, Inc operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. More about Bio-PathMarket Capitalization$1.12 millionConsensus RatingBuyConsensus Price Target$20.00 (+14,703.8% Upside)Volume3,724 sharesAverage Volume1.26 million sharesToday's Range$0.14▼$0.1514. T2 Biosystems NASDAQ:TTOO$0.12 +0.01 (+4.55%) As of 03:29 PM EasternT2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. More about T2 BiosystemsMarket Capitalization$2.42 millionConsensus RatingHoldConsensus Price Target$5.00 (+4,247.8% Upside)Volume34,647 sharesAverage Volume937,496 sharesToday's Range$0.11▼$0.1315. Aspira Women's Health NASDAQ:AWH$0.08 -0.01 (-12.49%) As of 04/16/2025Aspira Women's Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. More about Aspira Women's HealthMarket Capitalization$2.44 millionP/E Ratio-0.07Consensus RatingBuyConsensus Price Target$5.50 (+6,607.3% Upside)Volume4.31 million sharesAverage Volume1.26 million shares16. Cutera NASDAQ:CUTR$0.04 -0.07 (-63.86%) Closing price 03/12/2025Extended Trading$0.04 0.00 (0.00%) As of 03/12/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. More about CuteraMarket Capitalization$787 thousandP/E Ratio-0.01Consensus RatingModerate BuyConsensus Price Target$3.00 (+7,592.3% Upside)Volume27.70 million sharesAverage Volume2.34 million shares17. Leafly NASDAQ:LFLY$0.21 0.00 (-2.18%) As of 12:11 PM EasternLeafly Holdings, Inc owns and operates a platform to provide consumers with cannabis information and connects consumers to cannabis brands and licensed retailers. More about LeaflyMarket Capitalization$661 thousandP/E Ratio-0.09Consensus RatingBuyConsensus Price Target$9.18 (+4,171.8% Upside)Volume743 sharesAverage Volume367,584 shares18. Carisma Therapeutics NASDAQ:CARM$0.20 -0.01 (-3.00%) As of 03:24 PM EasternCarisma Therapeutics, Inc, a clinical-stage cell therapy company, focuses on discovering and developing immunotherapies to treat cancer and other serious diseases in the United States. More about Carisma TherapeuticsMarket Capitalization$8.24 millionP/E Ratio-0.13Consensus RatingHoldConsensus Price Target$1.93 (+876.7% Upside)Volume140,877 sharesAverage Volume379,855 shares19. Cannabist OTCMKTS:CBSTF$0.08 +0.01 (+21.08%) As of 04/29/2025 03:58 PM EasternThe Cannabist Company Holdings Inc engages in the cultivation, development, production, home delivery, and dispensary of cannabis products in the United States and internationally. More about CannabistConsensus RatingHoldVolume939,742 sharesAverage Volume928,447 sharesToday's Range$0.06▼$0.0850-Day Range$0.04▼$0.0852-Week Range$0.03▼$0.4420. Ayr Wellness OTCMKTS:AYRWF$0.21 +0.01 (+5.13%) As of 04/29/2025 03:57 PM EasternAyr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. More about Ayr WellnessMarket Capitalization$22.66 millionP/E Ratio-0.09Consensus RatingModerate BuyConsensus Price Target$3.00 (+1,363.4% Upside)Volume464,698 sharesAverage Volume309,656 shares21. Spruce Biosciences NASDAQ:SPRB$0.08 0.00 (-1.09%) As of 03:45 PM EasternSpruce Biosciences, Inc, a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. More about Spruce BiosciencesMarket Capitalization$3.46 millionP/E Ratio-0.09Consensus RatingHoldConsensus Price Target$2.17 (+2,542.3% Upside)Volume1.73 million sharesAverage Volume723,187 shares22. AIM ImmunoTech NYSE:AIM$0.09 -0.03 (-22.34%) As of 04/4/2025 This is a fair market value price provided by Polygon.io. Learn more.AIM ImmunoTech Inc, an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. More about AIM ImmunoTechMarket Capitalization$6.61 millionP/E Ratio-0.19Consensus RatingBuyConsensus Price Target$2.75 (+2,908.8% Upside)Volume2.31 million sharesAverage Volume537,449 shares23. Abpro NASDAQ:ABP$0.24 -0.02 (-8.88%) As of 03:21 PM EasternAbpro Holdings Inc is a biotechnology company. The company's mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. More about AbproMarket Capitalization$12.37 millionConsensus RatingBuyConsensus Price Target$4.00 (+1,588.5% Upside)Volume522,249 sharesAverage Volume196,928 sharesToday's Range$0.22▼$0.2624. Solo Brands NYSE:DTC$0.09 -0.01 (-7.54%) As of 04/22/2025 This is a fair market value price provided by Polygon.io. Learn more.Solo Brands, Inc operates a direct-to-consumer platform that offers outdoor and lifestyle branded products in the United States. More about Solo BrandsMarket Capitalization$8.71 millionP/E Ratio-0.03Consensus RatingHoldConsensus Price Target$1.18 (+1,144.7% Upside)Volume2.31 million sharesAverage Volume462,528 shares25. MariMed OTCMKTS:MRMD$0.11 +0.01 (+6.00%) As of 04/29/2025 03:43 PM EasternMariMed Inc engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. More about MariMedMarket Capitalization$40.44 millionP/E Ratio-2.65Consensus RatingStrong BuyVolume56,029 sharesAverage Volume393,857 sharesToday's Range$0.10▼$0.11 More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Hims & Hers Stock Soars on Novo Nordisk Collaboration 3 Dividend Kings Outshining the Market in 2025 Tesla's Band-Aid Has Been Ripped Off: Rally Mode Engaged Amazon's Earnings Will Make or Break the Stock's Comeback Why D-Wave's Project With Davidson Is a Game-Changer For Quantum NXP Semiconductors: A Buy-and-Hold Stock in the Buy Zone Joby Aviation Shares Eye Breakout After Transition Flight Win Altria’s Resilient Strategy Keeps It a Top Dividend Play in 2025 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
